Payment overview · 2025
General Payments
$340.30
5 reported records · 2 companies
Healthcare provider profile · identity verified
John Huang, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · WALLINGFORD, CT · NPI 1306860432
Verified facts
What the public records show
CMS Open Payments records show John Huang, M.D. received $340.30 in general payments during 2025 across 5 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 63.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 151 claims for Jardiance by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $215.30 | 63.3% | 4 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $125.00 | 36.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $340.30 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $125.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
151 | 52 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1103 | 319 |
| Amlodipine Besylate | Amlodipine Besylate | 809 | 247 |
| Levothyroxine Sodium | Levothyroxine Sodium | 625 | 176 |
| Lisinopril | Lisinopril | 509 | 143 |
| Simvastatin | Simvastatin | 412 | 110 |
| Pantoprazole Sodium | Pantoprazole Sodium | 386 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 359 | 105 |
| Metformin Hcl | Metformin Hcl | 354 | 112 |
| Losartan Potassium | Losartan Potassium | 352 | 103 |
| Alprazolam | Alprazolam | 350 | 82 |
| Omeprazole | Omeprazole | 349 | 93 |
| Metoprolol Succinate | Metoprolol Succinate | 342 | 96 |
| Tamsulosin Hcl | Tamsulosin Hcl | 304 | 92 |
| Gabapentin | Gabapentin | 293 | 86 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 279 | 84 |
| Metformin Hcl Er | Metformin Hcl | 276 | 79 |
| Hydrochlorothiazide | Hydrochlorothiazide | 275 | 87 |
| Furosemide | Furosemide | 274 | 89 |
| Zolpidem Tartrate | Zolpidem Tartrate | 234 | 38 |
| Trazodone Hcl | Trazodone Hcl | 215 | 60 |
| Metoprolol Tartrate | Metoprolol Tartrate | 207 | 62 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 199 | 70 |
| Allopurinol | Allopurinol | 193 | 60 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 166 | 24 |
| Tramadol Hcl | Tramadol Hcl | 164 | 46 |
| Oxycodone Hcl | Oxycodone Hcl | 155 | 23 |
| Lorazepam | Lorazepam | 154 | 42 |
| Potassium Chloride | Potassium Chloride | 153 | 33 |
| Jardiance | Empagliflozin | 151 | 52 |
| Lovastatin | Lovastatin | 144 | 35 |
| Ozempic | Semaglutide | 143 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 142 | 44 |
| Sertraline Hcl | Sertraline Hcl | 140 | 42 |
| Glimepiride | Glimepiride | 132 | 43 |
| Januvia | Sitagliptin Phosphate | 132 | 38 |
| Eliquis | Apixaban | 131 | 37 |
| Finasteride | Finasteride | 121 | 37 |
| Spironolactone | Spironolactone | 111 | 34 |
| Alendronate Sodium | Alendronate Sodium | 106 | 30 |
| Meloxicam | Meloxicam | 104 | 33 |
| Ezetimibe | Ezetimibe | 101 | 32 |
| Bupropion Xl | Bupropion Hcl | 99 | 29 |
| Clonazepam | Clonazepam | 99 | 24 |
| Atenolol | Atenolol | 98 | 28 |
| Famotidine | Famotidine | 98 | 28 |
| Synthroid | Levothyroxine Sodium | 96 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 95 | 44 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 87 | 76 |
| Clopidogrel | Clopidogrel Bisulfate | 86 | 29 |
| Pioglitazone Hcl | Pioglitazone Hcl | 86 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 84 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 81 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 81 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 78 | 25 |
| Diazepam | Diazepam | 75 | 16 |
| Xarelto | Rivaroxaban | 75 | 17 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 74 | 27 |
| Montelukast Sodium | Montelukast Sodium | 73 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 72 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 72 | 23 |
| Donepezil Hcl | Donepezil Hcl | 71 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 71 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | 20 |
| Carvedilol | Carvedilol | 65 | 22 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 62 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 20 |
| Buspirone Hcl | Buspirone Hcl | 60 | 19 |
| Doxazosin Mesylate | Doxazosin Mesylate | 58 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 58 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 58 | 20 |
| Methylprednisolone | Methylprednisolone | 58 | 50 |
| Mirtazapine | Mirtazapine | 57 | 19 |
| Glipizide Er | Glipizide | 56 | 24 |
| Trulicity | Dulaglutide | 56 | suppressed |
| Nystatin | Nystatin | 55 | 27 |
| Valsartan | Valsartan | 55 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 53 | 35 |
| Levetiracetam | Levetiracetam | 53 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 51 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 51 | 20 |
| Pregabalin | Pregabalin | 49 | 21 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 48 | suppressed |
| Ibuprofen | Ibuprofen | 46 | 17 |
| Farxiga | Dapagliflozin Propanediol | 45 | 12 |
| Amoxicillin | Amoxicillin | 43 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 20 |
| Levemir Flexpen | Insulin Detemir | 43 | 12 |
| Prednisone | Prednisone | 42 | 32 |
| Ramipril | Ramipril | 42 | suppressed |
| Tradjenta | Linagliptin | 42 | 14 |
| Ketoconazole | Ketoconazole | 41 | 19 |
| Lactulose | Lactulose | 41 | suppressed |
| Celecoxib | Celecoxib | 40 | 13 |
| Enalapril Maleate | Enalapril Maleate | 40 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 40 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 39 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | 16 |
| Ventolin Hfa | Albuterol Sulfate | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 38 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 38 | 38 |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 32 |
| Azithromycin | Azithromycin | 34 | 30 |
| Symbicort | Budesonide/Formoterol Fumarate | 34 | suppressed |
| Chlorthalidone | Chlorthalidone | 33 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 33 | 21 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | 14 |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | 11 |
| Baclofen | Baclofen | 31 | 17 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 31 | suppressed |
| Folic Acid | Folic Acid | 31 | suppressed |
| Glipizide | Glipizide | 30 | suppressed |
| Klor-Con M20 | Potassium Chloride | 30 | suppressed |
| Nifedipine Er | Nifedipine | 30 | 11 |
| Divalproex Sodium | Divalproex Sodium | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 23 |
| Nadolol | Nadolol | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 28 | suppressed |
| Carbamazepine Er | Carbamazepine | 27 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 27 | 11 |
| Naproxen | Naproxen | 27 | 12 |
| Testosterone | Testosterone | 27 | suppressed |
| Torsemide | Torsemide | 27 | suppressed |
| Lansoprazole | Lansoprazole | 26 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 26 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 20 |
| Clobazam | Clobazam | 23 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Levofloxacin | Levofloxacin | 23 | 21 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 23 | 11 |
| Fentanyl | Fentanyl | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Zaleplon | Zaleplon | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Felodipine Er | Felodipine | 20 | suppressed |
| Fluconazole | Fluconazole | 20 | 11 |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 20 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | 16 |
| Mometasone Furoate | Mometasone Furoate | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | 11 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Methadone Hcl | Methadone Hcl | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 18 | suppressed |
| Oxycontin | Oxycodone Hcl | 18 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Telmisartan | Telmisartan | 17 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Pioglitazone-Metformin | Pioglitazone Hcl/Metformin Hcl | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 13 |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Verapamil Er | Verapamil Hcl | 16 | suppressed |
| Acetazolamide | Acetazolamide | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 15 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Insulin Lispro | Insulin Lispro | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Ambien | Zolpidem Tartrate | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 13 | suppressed |
| Digoxin | Digoxin | 13 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 13 | suppressed |
| Flunisolide | Flunisolide | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Valium | Diazepam | 13 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Levocarnitine | Levocarnitine | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Otezla | Apremilast | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $340.30 · 5 records | Boehringer Ingelheim Pharmaceuticals, Inc. | REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error